Valbiotis, a French research and development company committed to preventing and combating metabolic...
Up to date
Appointments
Asceneuron, a company in the development of orally bioavailable modulators of tau pathology for the treatment...
Pharnext Announces the Appointments of Susanne Dorn as Chief Regulatory Officer and Serge Fitoussi as Chief...
Protagen AG, a precision medicine specialist at the forefront of immuno-profiling, announced today the...
Immunocore has appointed Bahija Jallal as Chief Executive Officer and Director of the Board.
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its Board of Directors has named Daniel O’Day...
Share
